San Diego, CA · Founded 2019 · Privately Held (backing)
Operator of a biotechnology company intended to discover innovative therapeutics for the treatment of cancers that are resistant to current therapies. 858 Therapeutics is based in San Diego, CA and was founded in 2019. Its last known valuation is $140 million. It has raised $110 million across 3 recorded rounds; the latest was a $25.2 million early-stage round in Jun 2024.
Last price · $/share
—
Implied valuation
$140.0M
Total raised
$110.0M
Last round
Early Stage VC
Jun 2024
Cap table — not yet on record
858 Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of 858 Therapeutics with a free account
·Watch 858 Therapeutics: the Monday email on marks, rounds and moves
Where does 858 Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across 858 Therapeutics's 3 recorded funding rounds.
